Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 16;65(1):e01849-20.
doi: 10.1128/AAC.01849-20. Print 2020 Dec 16.

In Vitro Susceptibility of Nocardia farcinica to the Antimycobacterial Drug Clofazimine

Ka Lip Chew  1 , Sophie Octavia  2 , Siang Fei Yeoh  3 , Jeanette W P Teo  4
Affiliations

In Vitro Susceptibility of Nocardia farcinica to the Antimycobacterial Drug Clofazimine

Ka Lip Chew et al. Antimicrob Agents Chemother. .
No abstract available

Keywords: Nocardia farcinica; bedaquiline; clofazimine; nocardiosis; rifabutin.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Restrepo A, Clark NM, Infectious Diseases Community of Practice of the American Society of Transplantation. 2019. Nocardia infections in solid organ transplantation: guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation. Clin Transplant 33:e13509. doi:10.1111/ctr.13509. - DOI - PubMed
    1. Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ. 2006. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev 19:259–282. doi:10.1128/CMR.19.2.259-282.2006. - DOI - PMC - PubMed
    1. Aziz DB, Low JL, Wu M-L, Gengenbacher M, Teo JWP, Dartois V, Dick T. 2017. Rifabutin is active against Mycobacterium abscessus complex. Antimicrob Agents Chemother 61:e00155-17. doi:10.1128/AAC.00155-17. - DOI - PMC - PubMed
    1. Cholo MC, Mothiba MT, Fourie B, Anderson R. 2017. Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline. J Antimicrob Chemother 72:338–353. doi:10.1093/jac/dkw426. - DOI - PubMed
    1. Nguyen TVA, Anthony RM, Bañuls A-L, Nguyen TVA, Vu DH, Alffenaar JC. 2018. Bedaquiline resistance: its emergence, mechanism, and prevention. Clin Infect Dis 66:1625–1630. doi:10.1093/cid/cix992. - DOI - PubMed

Publication types

Supplementary concepts